These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 31082457)

  • 1. Blocking histone deacetylase activity as a novel target for epithelial barrier defects in patients with allergic rhinitis.
    Steelant B; Wawrzyniak P; Martens K; Jonckheere AC; Pugin B; Schrijvers R; Bullens DM; Vanoirbeek JA; Krawczyk K; Dreher A; Akdis CA; Hellings PW
    J Allergy Clin Immunol; 2019 Nov; 144(5):1242-1253.e7. PubMed ID: 31082457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression.
    Steelant B; Farré R; Wawrzyniak P; Belmans J; Dekimpe E; Vanheel H; Van Gerven L; Kortekaas Krohn I; Bullens DMA; Ceuppens JL; Akdis CA; Boeckxstaens G; Seys SF; Hellings PW
    J Allergy Clin Immunol; 2016 Apr; 137(4):1043-1053.e5. PubMed ID: 26846377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis.
    Steelant B; Seys SF; Van Gerven L; Van Woensel M; Farré R; Wawrzyniak P; Kortekaas Krohn I; Bullens DM; Talavera K; Raap U; Boon L; Akdis CA; Boeckxstaens G; Ceuppens JL; Hellings PW
    J Allergy Clin Immunol; 2018 Mar; 141(3):951-963.e8. PubMed ID: 29074456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease.
    Pothoven KL; Norton JE; Hulse KE; Suh LA; Carter RG; Rocci E; Harris KE; Shintani-Smith S; Conley DB; Chandra RK; Liu MC; Kato A; Gonsalves N; Grammer LC; Peters AT; Kern RC; Bryce PJ; Tan BK; Schleimer RP
    J Allergy Clin Immunol; 2015 Sep; 136(3):737-746.e4. PubMed ID: 25840724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients.
    Wawrzyniak P; Wawrzyniak M; Wanke K; Sokolowska M; Bendelja K; Rückert B; Globinska A; Jakiela B; Kast JI; Idzko M; Akdis M; Sanak M; Akdis CA
    J Allergy Clin Immunol; 2017 Jan; 139(1):93-103. PubMed ID: 27312821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase activity is a novel target for epithelial barrier defects in patients with eosinophilic chronic rhinosinusitis with nasal polyps.
    Duan S; Han X; Jiao J; Wang M; Li Y; Wang Y; Zhang L
    Clin Exp Allergy; 2023 Apr; 53(4):443-454. PubMed ID: 36458367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of forkhead box C1 reduces nasal epithelial barrier damage in mice with allergic rhinitis via epigenetically upregulating secreted frizzled-related protein 5.
    Shi Z; Zhao T; Li D; Wang C; Luo Y; Zheng Y
    Mol Immunol; 2024 Apr; 168():51-63. PubMed ID: 38422887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear erythroid 2-related factor 2 activation inhibits house dust mite-induced sinonasal epithelial cell barrier dysfunction.
    London NR; Tharakan A; Lane AP; Biswal S; Ramanathan M
    Int Forum Allergy Rhinol; 2017 May; 7(5):536-541. PubMed ID: 28151586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients.
    Sugita K; Steer CA; Martinez-Gonzalez I; Altunbulakli C; Morita H; Castro-Giner F; Kubo T; Wawrzyniak P; Rückert B; Sudo K; Nakae S; Matsumoto K; O'Mahony L; Akdis M; Takei F; Akdis CA
    J Allergy Clin Immunol; 2018 Jan; 141(1):300-310.e11. PubMed ID: 28392332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC Downregulation of Xiaoqinglong Decoction in the Treatment of Allergic Rhinitis.
    Liu HL; Chen HF; Liu QD; Xu WZ; Zhang JJ; He XC; Yan YJ; Ruan Y; Zhou M
    Int Arch Allergy Immunol; 2023; 184(4):376-390. PubMed ID: 36603560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal Epithelial Barrier Integrity and Tight Junctions Disruption in Allergic Rhinitis: Overview and Pathogenic Insights.
    Nur Husna SM; Tan HT; Md Shukri N; Mohd Ashari NS; Wong KK
    Front Immunol; 2021; 12():663626. PubMed ID: 34093555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zonula occludens-1 expression is reduced in nasal epithelial cells of allergic rhinitis patients.
    Siti Sarah CO; Nur Husna SM; Md Shukri N; Wong KK; Mohd Ashari NS
    PeerJ; 2022; 10():e13314. PubMed ID: 35480562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diesel exhaust particles exacerbate allergic rhinitis in mice by disrupting the nasal epithelial barrier.
    Fukuoka A; Matsushita K; Morikawa T; Takano H; Yoshimoto T
    Clin Exp Allergy; 2016 Jan; 46(1):142-52. PubMed ID: 26201369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIF signaling blocking alleviates airway inflammation and airway epithelial barrier disruption in a HDM-induced asthma model.
    Lan H; Luo L; Chen Y; Wang M; Yu Z; Gong Y
    Cell Immunol; 2020 Jan; 347():103965. PubMed ID: 31708110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-29a-3p promotes nasal epithelial barrier dysfunction via direct targeting of CTNNB1-VCL module in allergic rhinitis.
    Wang N; Li P; Liu J; Wang Z
    Int Immunopharmacol; 2023 Jul; 120():110325. PubMed ID: 37262956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC inhibitor sodium butyrate prevents allergic rhinitis and alters lncRNA and mRNA expression profiles in the nasal mucosa of mice.
    Wang J; Cui M; Sun F; Zhou K; Fan B; Qiu JH; Chen FQ
    Int J Mol Med; 2020 Apr; 45(4):1150-1162. PubMed ID: 32124940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piper Nigrum extract improves OVA-induced nasal epithelial barrier dysfunction via activating Nrf2/HO-1 signaling.
    Bui TT; Fan Y; Piao CH; Nguyen TV; Shin DU; Jung SY; Hyeon E; Song CH; Lee SY; Shin HS; Chai OH
    Cell Immunol; 2020 May; 351():104035. PubMed ID: 32051090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Effect of Histone Deacetylase Inhibitor, Sodium Butyrate, on Allergic Rhinitis In Vivo.
    Wang J; Wen L; Wang Y; Chen F
    DNA Cell Biol; 2016 Apr; 35(4):203-8. PubMed ID: 26859163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis.
    Doulaptsi M; Wils T; Hellings PW; Martens K; Farré R; Vicario M; Fokkens W; Prokopakis E; Steelant B
    World Allergy Organ J; 2021 Sep; 14(9):100585. PubMed ID: 34567350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cystatin SN is an endogenous protease inhibitor that prevents allergic rhinitis.
    Fukuoka A; Matsushita K; Morikawa T; Adachi T; Yasuda K; Kiyonari H; Fujieda S; Yoshimoto T
    J Allergy Clin Immunol; 2019 Mar; 143(3):1153-1162.e12. PubMed ID: 30012514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.